Search

Your search keyword '"Sorensen, Per Soelberg"' showing total 301 results

Search Constraints

Start Over You searched for: Author "Sorensen, Per Soelberg" Remove constraint Author: "Sorensen, Per Soelberg"
Sorry, I don't understand your search. ×
301 results on '"Sorensen, Per Soelberg"'

Search Results

1. The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

2. Fitbeat: COVID-19 Estimation based on Wristband Heart Rate

3. Using smartphones and wearable devices to monitor behavioural changes during COVID-19

7. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

9. The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

10. Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder

11. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

12. A wearable device perspective on the standard definitions of disability progression in multiple sclerosis

19. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

22. Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

29. Segmenting Multiple Sclerosis Lesions Using a Spatially Constrained K-Nearest Neighbour Approach

30. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

31. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

33. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

36. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

43. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

Catalog

Books, media, physical & digital resources